Search clinical trials for: Autologous Hematopoietic Stem cells (HSCs)

Total 3821 results

Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Terminated

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Minimal Residual Disease | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic... and other conditions

United States
Joshua M Hare

Withdrawn

The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial. (TAC-HFT-II)

Myocardial Infarction | Chronic Ischemic Left Ventricular Dysfunction

United States
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma

Lymphoma

China
Northwestern University

Terminated

Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis

Sarcoidosis

United States
Shenzhen Hemogen

Recruiting

the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia

β-thalassemia

China
Hospital e Maternidade Dr. Christóvão da Gama
IEP São Lucas - Instituto de Ensino e Pesquisa; Clinica Jordy Sinapse; TECHLIFE...

Completed

Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients

Motor Neuron Disease

Brazil
Gary A Levy, O. Ont. MD. FRCP AGAF
Ottawa Hospital Research Institute

Completed

Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)

Complication of Transplanted Organ, Nos

Canada
University of California, Los Angeles

Withdrawn

Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment (HSCT)

Crohn's Disease

United States
Shenzhen Hemogen

Recruiting

the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia

α-thalassemia

China
Bioray Laboratories
First Affiliated Hospital of Guangxi Medical University

Suspended

Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells

Thalassemia Major

China
Bioray Laboratories
Xiangya Hospital of Central South University; The 923rd Hospital of Joint Logistics...

Completed

Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells

β Thalassemia Major

China
Shenzhen Hemogen

Recruiting

Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients

β-thalassemia

China
Al-Azhar University
Cairo University

Completed

MSCs For Treatment of Azoospermic Patients

Male Infertility

Egypt
Centro de Hematología y Medicina Interna

Enrolling by invitation

Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells

Multiple Sclerosis
Clinica Universidad de Navarra, Universidad de...

Completed

Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue

Crohn Disease

Spain
European Society for Blood and Marrow Transplantation
The Broad Foundation

Terminated

ASTIC Autologous Stem Cell Transplantation for Crohn's Disease

Crohn Disease

United Kingdom, Italy, Switzerland, Belgium, Canada, France, Spain
Mayo Clinic
National Cancer Institute (NCI)

Completed

Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma

Lymphoma

United States
Roswell Park Cancer Institute
Celgene

Withdrawn

Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Blasts Under 5 Percent of Peripheral Blood White Cells | Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment Level

United States
University Hospital, Toulouse
Centre National de la Recherche Scientifique, France; French Blood Establishment and other collaborators

Completed

Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine (ACELLDREAM)

Cardiovascular Diseases | Peripheral Vascular Diseases

France
Bioray Laboratories
First Affiliated Hospital of Guangxi Medical University

Not yet recruiting

Clinical Study of BRL-101 in Severe SCD

Sickle Cell Disease

China
Joshua Sasine, MD, PhD

Recruiting

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Multiple Myeloma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Hematologic Malignancy | Large B-cell Lymphoma

United States
Institute of Hematology & Blood Diseases Hospital
Cellular Biomedicine Group Ltd.

Recruiting

ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)

Multiple Myeloma

China
Bioray Laboratories
Nanfang Hospital, Southern Medical University

Not yet recruiting

Clinical Study of BRL-101 in the Treatment of Sickle Cell Disease

Sickle Cell Disease
University College, London

Unknown

Autologous Stem Cells in Achilles Tendinopathy (ASCAT)

Tendinopathy | Achilles Tendinitis | Achilles Degeneration | Achilles Tendinitis, Right Leg | Achilles Tendon Thickening | Achilles Tendinitis, Left Leg

United Kingdom
University Hospitals Cleveland Medical Center
Case Western Reserve University

Recruiting

Impact of Mesenchymal Stem Cells in Knee Osteoarthritis

Musculoskeletal Pain | Knee Osteoarthritis | Cartilage Injury | Cartilage Degeneration

United States
Bioray Laboratories
Chinese Academy of Medical Sciences

Not yet recruiting

Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease

Sickle Cell Disease
Joshua M Hare
The Emmes Company, LLC

Completed

The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) (Trident)

Myocardial Infarction | Chronic Ischemic Left Ventricular Dysfunction

United States
Children's Hospital Medical Center, Cincinnati

Terminated

TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders

Allogeneic Hematopoietic Cell Transplantation

United States
Bioray Laboratories
Xiangya Hospital of Central South University; First Affiliated Hospital of... and other collaborators

Enrolling by invitation

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

Beta-Thalassemia

China
Abu Dhabi Stem Cells Center

Completed

Safety and Tolerability of Autologous Non-hematopoietic Peripheral Blood Stem Cells Therapy in Healthy Adult Volunteers. (SANTANA)

Healthy

United Arab Emirates
Beneficência Portuguesa de São Paulo

Active, not recruiting

Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease (AutoChron)

Gastroenteritis | Inflammatory Bowel Diseases | Crohn's Disease

Brazil
James Baumgartner, MD
CBR Systems, Inc.

Completed

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

Sensorineural Hearing Loss

United States
Instituto de Investigación Hospital Universitario...

Completed

Stem Cells Treatment for the Local Urinary Incontinence After a Radical Prostate Cancer Surgery (HULPURO) (FLPURO)

Urinary Incontinence

Spain
Ottawa Hospital Research Institute
Multiple Sclerosis Scientific Research Foundation

Completed

Autologous Stem Cell Transplant for Multiple Sclerosis (MS/BMT)

Multiple Sclerosis

Canada
Nanfang Hospital, Southern Medical University
Zhujiang Hospital

Completed

Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+

Acute Myeloid Leukemia | Risk Stratification
University of Florida
Oligo Nation, Inc

Not yet recruiting

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients (ADAGiO)

Recurrent Oligodendroglioma | Progressive Oligodendroglioma

United States
Chaitanya Hospital, Pune

Unknown

Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease (OND)

Optic Atrophy

India
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

Mantle Cell Lymphoma | CD20 Positive

United States
Emory University
National Cancer Institute (NCI); Gateway for Cancer Research

Recruiting

Personalized Autologous Transplant for Multiple Myeloma

Multiple Myeloma

United States
The University of Texas Health Science Center,...
Cord Blood Registry (CBR); Let's Cure CP Foundation; Mission Connect, a program...

Completed

Safety and Effectiveness of Banked Cord Blood or Bone Marrow Stem Cells in Children With Cerebral Palsy (CP). (ACT for CP)

Cerebral Palsy

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma

Plasma Cell Myeloma

United States
University of Zurich

Recruiting

Pilot Feasibility Study of Combined Kidney and Hematopoietic Stem Cell Transplantation to Cure End-stage Renal Disease

End Stage Renal Disease

Switzerland
Navy General Hospital, Beijing
Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese... and other collaborators

Unknown

Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

Severe Aplastic Anemia

China
Hospital Universitario Dr. Jose E. Gonzalez

Unknown

Autologous Bone Marrow Stem Cells for Children With Autism Spectrum Disorders (Autism)

Autism | Autism Spectrum

Mexico
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

Neoplasms | Hematologic Diseases

China
Chongqing University Cancer Hospital

Recruiting

Chemotherapy Supported by Autologous Hematopoietic Stem Cells

Ovarian Cancer

China
Uppsala University Hospital

Terminated

Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study

Type 1 Diabetes Mellitus

Sweden
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Guangzhou First... and other collaborators

Unknown

Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease

Acute Graft-versus-host Disease

China
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-sen University; Guangzhou First... and other collaborators

Unknown

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

Chronic Graft-versus-host Disease

China
Chongqing University Cancer Hospital

Recruiting

Hematopoietic Stem Cell-containing Autologous Blood Transfusion for Bone Marrow Protection in Patients With Cervical Cancer

Cervical Cancer

China

Search clinical trials for: Autologous Hematopoietic Stem cells (HSCs)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations